Amgen 2006 Annual Report Download - page 24

Download and view the complete annual report

Please find page 24 of the 2006 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 38

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38

Amgen 2006 Annual Report 22
“The earlier we can intervene
in the progression of kidney
disease, the better chance
patients have to manage it.”
“I want to finish school and my
job training. I do not want to be
treated like a seriously ill person.”
Kathrin Nöckel, Aranesp® (darbepoetin alfa) patient
Eighteen-year-old Nöckel is a home economics student in Wildeshausen,
Germany. She has been living with multicystic renal dysplasia, a
nonhereditary renal disease, since birth. For over a year she has been
receiving weekly doses of Aranesp® to help control her anemia.
Thomas Pacheco, phlebotomist, Porter Hospital Education and
Rehabilitation Center
A health care professional for many years, Pacheco draws blood at
a KEEP kidney health screening in Valparaiso, Indiana. Test results
from KEEP screenings provide patients with information that may
prompt them to seek medical attention in the early stages of diabetes
and other diseases that affect kidney function.